Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
August 17, 2016
AUDENTES THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN THE INCEPTUS CLINICAL ASSESSMENT STUDY OF XLMTM
August 11, 2016
CIDARA REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
August 9, 2016
CIDARA THERAPEUTICS ANNOUNCES PRESENTATIONS ADDRESSING VULVOVAGINAL CANDIDIASIS AT UPCOMING IDSOG ANNUAL MEETING
August 8, 2016
CLEAVE BIOSCIENCES RAISES $37 MILLION SERIES B FINANCING
July 27, 2016
MILLENDO THERAPEUTICS ANNOUNCES PUBLICATION OF POSITIVE PHASE 2A DATA FOR MLE4901 FOR THE TREATMENT OF POLYCYSTIC OVARY SYNDROME
July 21, 2016
GALENICA AND RELYPSA ANNOUNCE AGREEMENT FOR GALENICA TO ACQUIRE RELYPSA
July 19, 2016
AUDENTES THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
July 12, 2016
SUPERNUS PHARMACEUTICALS FOUNDER AND CEO JACK KHATTAR JOINS SCPHARMACEUTICALS BOARD OF DIRECTORS
June 14, 2016
VIVEVE® ANNOUNCES PRICING OF $13.5 MILLION PUBLIC OFFERING OF SHARES OF COMMON STOCK AND NASDAQ UPLISTING
June 9, 2016
CIDARA DOSES FIRST PATIENT IN PHASE 2 TRIAL OF CD101 TOPICAL TO TREAT VULVOVAGINAL CANDIDIASIS
« Previous Page
1
…
92
93
94
95
96
…
119
Next Page »